Clinical trial design in the neurocritical care unit

C. E. Hall, M. Mirski, Y. Y. Palesch, M. N. Diringer, A. I. Qureshi, C. S. Robertson, R. Geocadin, C. A C Wijman, P. D. Le Roux, Jose I. Suarez

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

Original languageEnglish (US)
Pages (from-to)6-19
Number of pages14
JournalNeurocritical Care
Volume16
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Practice Guidelines
Clinical Trials
Quality of Health Care
Nervous System Diseases
Intensive Care Units
Patient Care
Growth

Keywords

  • Funding
  • Industry
  • Neurocritical care
  • NIH
  • Surrogate markers

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine

Cite this

Hall, C. E., Mirski, M., Palesch, Y. Y., Diringer, M. N., Qureshi, A. I., Robertson, C. S., ... Suarez, J. I. (2012). Clinical trial design in the neurocritical care unit. Neurocritical Care, 16(1), 6-19. https://doi.org/10.1007/s12028-011-9608-6

Clinical trial design in the neurocritical care unit. / Hall, C. E.; Mirski, M.; Palesch, Y. Y.; Diringer, M. N.; Qureshi, A. I.; Robertson, C. S.; Geocadin, R.; Wijman, C. A C; Le Roux, P. D.; Suarez, Jose I.

In: Neurocritical Care, Vol. 16, No. 1, 02.2012, p. 6-19.

Research output: Contribution to journalArticle

Hall, CE, Mirski, M, Palesch, YY, Diringer, MN, Qureshi, AI, Robertson, CS, Geocadin, R, Wijman, CAC, Le Roux, PD & Suarez, JI 2012, 'Clinical trial design in the neurocritical care unit', Neurocritical Care, vol. 16, no. 1, pp. 6-19. https://doi.org/10.1007/s12028-011-9608-6
Hall CE, Mirski M, Palesch YY, Diringer MN, Qureshi AI, Robertson CS et al. Clinical trial design in the neurocritical care unit. Neurocritical Care. 2012 Feb;16(1):6-19. https://doi.org/10.1007/s12028-011-9608-6
Hall, C. E. ; Mirski, M. ; Palesch, Y. Y. ; Diringer, M. N. ; Qureshi, A. I. ; Robertson, C. S. ; Geocadin, R. ; Wijman, C. A C ; Le Roux, P. D. ; Suarez, Jose I. / Clinical trial design in the neurocritical care unit. In: Neurocritical Care. 2012 ; Vol. 16, No. 1. pp. 6-19.
@article{b24c59e81b9146068ca52ab294a58484,
title = "Clinical trial design in the neurocritical care unit",
abstract = "Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.",
keywords = "Funding, Industry, Neurocritical care, NIH, Surrogate markers",
author = "Hall, {C. E.} and M. Mirski and Palesch, {Y. Y.} and Diringer, {M. N.} and Qureshi, {A. I.} and Robertson, {C. S.} and R. Geocadin and Wijman, {C. A C} and {Le Roux}, {P. D.} and Suarez, {Jose I.}",
year = "2012",
month = "2",
doi = "10.1007/s12028-011-9608-6",
language = "English (US)",
volume = "16",
pages = "6--19",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Clinical trial design in the neurocritical care unit

AU - Hall, C. E.

AU - Mirski, M.

AU - Palesch, Y. Y.

AU - Diringer, M. N.

AU - Qureshi, A. I.

AU - Robertson, C. S.

AU - Geocadin, R.

AU - Wijman, C. A C

AU - Le Roux, P. D.

AU - Suarez, Jose I.

PY - 2012/2

Y1 - 2012/2

N2 - Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

AB - Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

KW - Funding

KW - Industry

KW - Neurocritical care

KW - NIH

KW - Surrogate markers

UR - http://www.scopus.com/inward/record.url?scp=84861094797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861094797&partnerID=8YFLogxK

U2 - 10.1007/s12028-011-9608-6

DO - 10.1007/s12028-011-9608-6

M3 - Article

VL - 16

SP - 6

EP - 19

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

IS - 1

ER -